These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8190022)

  • 1. Stimulation of insulin receptor tyrosine kinase activity by an amino terminal sequence of human growth hormone.
    Lim N; Wijaya E; Ng F
    Life Sci; 1994; 54(20):1471-81. PubMed ID: 8190022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of hepatic insulin receptors by a human growth hormone fragment (hGH 6-13).
    Ng F; Henderson T; Bromley J; Bornstein J
    Mol Cell Endocrinol; 1983 Apr; 30(1):63-71. PubMed ID: 6341118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The minimal amino acid sequence of the insulin-potentiating fragments of human growth hormone: its mechanism of action.
    Ng FM; Bornstein J; Pullin CE; Bromley JO; Macaulay SL
    Diabetes; 1980 Oct; 29(10):782-7. PubMed ID: 6777219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemic action of a novel constrained analog of human growth hormone-(6-13).
    Lim N; Ng FM; Wu ZM; Ede N; Hearn MT
    Endocrinology; 1992 Aug; 131(2):835-40. PubMed ID: 1639027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and conformation of constrained peptides with hypoglycaemic activity derived from human growth hormone.
    Ede NJ; Rae ID; Hearn MT
    Int J Pept Protein Res; 1994 Dec; 44(6):568-81. PubMed ID: 7705979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of cellular actions between gliclazide and a hypoglycaemic peptide fragment of human growth hormone (hGH 6-13).
    Ng FM
    Diabetes Res Clin Pract; 1988 May; 5(1):17-24. PubMed ID: 3042343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic effect of a hypoglycaemic fragment of human growth hormone (hGH 6-13).
    Ng FM; Rotstein T
    Diabetes Res; 1988 Mar; 7(3):103-8. PubMed ID: 3046817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of 2-deoxyglucose uptake in rat adipocytes by a human growth hormone fragment (hGH 4-15).
    Ng FM; Harcourt JA
    Diabetologia; 1986 Dec; 29(12):882-7. PubMed ID: 3569692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cellular mediator for the hypoglycemic action of a human growth hormone fragment (hGH 4-15).
    Ng FM; Blaskett E; Larsen-Disney P
    Biochem Int; 1985 Nov; 11(5):739-46. PubMed ID: 4091848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an antilipogenic fragment of human growth hormone on glucose transport in rat adipocytes.
    Wijaya E; Ng FM
    Biochem Mol Biol Int; 1993 Nov; 31(3):543-52. PubMed ID: 8118430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-potentiating action of a synthetic amino-terminal fragment of human growth hormone (hGH 1--15) in streptozotocin-diabetic rats.
    Ng FM; Bornstein J
    Diabetes; 1979 Dec; 28(12):1126-30. PubMed ID: 510810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antilipogenic action of synthetic C-terminal sequence 177-191 of human growth hormone.
    Wu Z; Ng FM
    Biochem Mol Biol Int; 1993 May; 30(1):187-96. PubMed ID: 8358331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of 3-O-methylglucose transport in adipocytes by a synthetic human growth hormone fragment.
    Ng FM; Hoich RI
    Biochem Int; 1985 Mar; 10(3):507-16. PubMed ID: 3893436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analyses of insulin-potentiating fragments of human growth hormone by computative simulation; essential unit for insulin-involved biological responses.
    Ohkura K; Hori H
    Bioorg Med Chem; 2000 Jul; 8(7):1733-40. PubMed ID: 10976521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel insulin-like actions of human growth hormone and its part sequence hGH 7-13.
    Armstrong JM; Bornstein J; Bromley JO; Macaulay SL; Ng FM
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):492-8. PubMed ID: 6405571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amino-terminal peptide of growth hormone enhances insulin action in normal rats.
    Mondon CE; Reaven GM; Ling N; Lewis UJ; Frigeri LG
    Endocrinology; 1988 Aug; 123(2):827-33. PubMed ID: 3135175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of hypophysectomy and the insulin-like and anti-insulin pituitary peptides on carbohydrate metabolism in yellow Avy/A (BALB/c x VY)F1 hybrid mice.
    Salem MA; Lewis UJ; Haro LS; Kishi K; McAllister DL; Seavey BK; Bee G; Wolff GL
    Proc Soc Exp Biol Med; 1989 Sep; 191(4):408-19. PubMed ID: 2672006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation between insulin receptor occupancy and tyrosine kinase activity at low insulin concentrations and effect of major histocompatibility complex class I-derived peptide.
    Stagsted J; Hansen T; Roth RA; Goldstein A; Olsson L
    J Pharmacol Exp Ther; 1993 Nov; 267(2):997-1001. PubMed ID: 8246175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of C-terminal chain shortening on the insulin-antagonistic activity of human growth hormone 177--191.
    Wade JD; Ng FM; Bornstein J; Pullin CO; Pearce JS
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):10-4. PubMed ID: 6751009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of tyrosine-containing polymers to characterize the substrate specificity of insulin and other hormone-stimulated tyrosine kinases.
    Zick Y; Grunberger G; Rees-Jones RW; Comi RJ
    Eur J Biochem; 1985 Apr; 148(1):177-82. PubMed ID: 2983990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.